Lee Johnson Capital Management, LLC Bristol Myers Squibb CO Transaction History

Lee Johnson Capital Management, LLC

  • $194 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023
BUY
$68.48 - $81.09 $18,832 - $22,299
275 Added 1.52%
18,403 $1.32 Million
Q3 2022

Oct 28, 2022
BUY
$0.13 - $76.84 $28 - $16,597
216 Added 1.21%
18,128 $1.29 Million
Q2 2022

Jul 13, 2022
BUY
$72.62 - $79.98 $62,816 - $69,182
865 Added 5.07%
17,912 $1.38 Million
Q1 2022

Apr 26, 2022
BUY
$61.48 - $73.72 $8,976 - $10,763
146 Added 0.86%
17,047 $1.25 Million
Q4 2021

Jan 31, 2022
BUY
$53.63 - $62.52 $906,400 - $1.06 Million
16,901 New
16,901 $1.05 Million

Others Institutions Holding BMY

# of Institutions
2,533
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Lee Johnson Capital Management, LLC Portfolio

Follow Lee Johnson Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lee Johnson Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lee Johnson Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email